Patient specific circulating tumor DNA fingerprints to monitor treatment response across multiple tumors

BACKGROUND: Circulating tumor DNA (ctDNA) offers a convenient way to monitor tumor progression and treatment response. Because tumor mutational profiles are highly variable from person to person, a fixed content panel may be insufficient to track treatment response in all patients. METHODS: We desig...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jiaping, Jiang, Wei, Wei, Jinwang, Zhang, Jianwei, Cai, Linbo, Luo, Minjie, Wang, Zhan, Sun, Wending, Wang, Shengzhou, Wang, Chen, Dai, Chun, Liu, Jun, Wang, Guan, Wang, Jiping, Xu, Qiang, Deng, Yanhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395971/
https://www.ncbi.nlm.nih.gov/pubmed/32738923
http://dx.doi.org/10.1186/s12967-020-02449-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395971/
https://www.ncbi.nlm.nih.gov/pubmed/32738923
http://dx.doi.org/10.1186/s12967-020-02449-y

Ejemplares similares